정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
---|---|---|---|---|---|---|---|---|---|---|---|
9 | Not yet recruiting | World Health Organization (WHO) COVID-19 Solidarity Trial for COVID-19 Treatments | Covid19 | Drug: Remdesivir Drug: Acalabrutinib Drug: Interferon beta-1a Other: Standard of Care |
Phase 3 | The University of The West Indies | OTHER | 100 | All | 18 Years ~ 100 Years | Univeristy of the West Indies, Kingston, Jamaica |
8 | Completed | Xylocaine to Freeze During Unpleasant Nasopharyngeal Swabs | Covid19 | Drug: Xylocaine Drug: Placebo |
Phase 3 | Evelyne D.Trottier | OTHER | 88 | All | 8 Years ~ 17 Years | Evelyne D Trottier, Montreal, Quebec, Canada |
7 | Suspended | Yinhu Qingwen Decoction for the Treatment of Mild / Common CoVID-19 | Chinese Medicine | Drug: YinHu QingWen Decoction Drug: YinHu QingWen Decoction(low dose) Other: Chinese medicine treatment Other: standard western medicine treatment |
Phase 3 | China Academy of Chinese Medical Sciences | OTHER | 300 | All | 18 Years | Jingzhou Hospital of Traditional Chinese Medicine, Jingzhou, Hubei, China Wuhan Leishenshan (Thunder God Mountain) Hospital/The First Affiliated Hospital of Dalian Medical University, Wuhan, Hubei, China Xiangyang Hospital of Traditional Chinese Medicine, Xiangyang, Hubei, China |
6 | Suspended | Yinhu Qingwen Granula for the Treatment of Severe CoVID-19 | Chinese Medicine | Drug: Yinhu Qingwen Granula Drug: Yin Hu Qing Wen Granula(low does) Other: standard medical treatment |
Phase 3 | Zhong Wang, Wuhan Leishenshan Hospital, The First Affiliated Hospital of Dalian Medical University, Tanshan People's Hospital, North China University of Science and Technology Affiliated Hospital, Jizhong Energy Fengfeng Group Hospital | OTHER | 116 | All | 18 Years | Wuhan No.7 Hospital/Jizhong Energy Fengfeng Group Hospital, Wuhan, Hubei, China Wuhan No.7 Hospital/North China University of Science and Technology Affiliated Hospital, Wuhan, Hubei, China Zhongnan Hospital of Wuhan University/Tanshan People's Hospital, Wuhan, Hubei, China Wuhan Leishenshan (Thunder God Mountain) Hospital/The First Affiliated Hospital of Dalian Medical University, Wuhan, Hubei, China |
5 | Completed | Zilucoplan® in Improving Oxygenation and Short- and Long-term Outcome of COVID-19 Patients With Acute Hypoxic Respiratory Failure | COVID-19 | Drug: Zilucoplan® Drug: Placebo |
Phase 2 | University Hospital, Ghent, UCB Pharma | OTHER | 81 | All | 18 Years | OLVZ Aalst, Aalst, Belgium AZ Sint Jan Brugge, Brugge, Belgium Erasmus University Hospital, Brussels, Belgium AZ Sint-Lucas, Gent, Belgium University Hospital Ghent, Gent, Belgium Jan Yperman Ziekenhuis Ieper, Ieper, Belgium University Hospital Liege, Liege, Belgium AZ Delta, Roeselare, Belgium AZ Vesalius, Tongeren, Belgium |
4 | Not yet recruiting | Zinc and Green Tea Extract for Community Respiratory Viral Infections | Respiratory Viral Infection | Drug: zinc-green tea extract-ascorbic acid | Phase 2 | University of Missouri-Columbia | OTHER | 100 | All | 18 Years | |
3 | Recruiting | Zinc With Chloroquine/Hydroxychloroquine in Treatment of COVID-19 | COVID | Drug: Chloroquine Drug: zinc |
Phase 3 | Tanta University | OTHER | 200 | All | 18 Years | Tanta university hospital, Assuit University, Ainshams University, Tanta, Egypt |